What Nanodropper does

Nanodropper is a privately held US medical device company (Delaware-incorporated) that designs, manufactures, and distributes a microvolume eyedrop delivery adaptor. The core product is an FDA-listed sterile Class I medical device that twists onto standard eyedrop bottles (in Size 14 and Size 15 variants covering the vast majority of US bottles) to reduce dispensed drop volume from the conventional 30-50 μL down to 7-10 μL — a level aligned with the human eye's accommodation capacity and decades of clinical research establishing that smaller drops are equally effective. The company sells the device through three primary channels: direct-to-consumer e-commerce (nanodropper.com), Amazon marketplace (featured on Amazon Buy It Now), and wholesale accounts for eye care professionals, supported by a partner clinic network of 3,000+ clinics across all 50 states. Pricing is positioned around a one-time per-bottle unit purchase with a 20% bulk discount for 4+ units, FSA/HSA eligibility, and a 14-day risk-free trial, with the marketing message centered on extending medication bottle life by up to 3x and reducing prescription costs for patients on expensive branded glaucoma, dry eye, cataract recovery, and pediatric myopia drops.

The company was founded in 2017 by Dr. Allisa Song and operates with a small team (11-50 employees) headquartered in Rochester, Minnesota. Clinical evidence is a central pillar of the business: a peer-reviewed randomized crossover trial published in the Journal of Cataract & Refractive Surgery demonstrated superior IOP reduction (1.6 mm Hg vs 0.13 mm Hg), 80% reduction in premature bottle exhaustion, and 62% vs 83% adverse-effect rates versus conventional drops, with additional work published in Ophthalmology. Beyond the core adaptor, Nanodropper launched the Eye Drop Score patient self-assessment quiz in March 2026, and in January 2026 announced a consolidation with Bedo Solutions and Viseon Labs under a new corporate identity called Mu Medical — a medtech platform play extending into drug delivery, home monitoring, and AI-driven clinical intelligence across four product verticals.

Nanodropper's commercial model combines product-led growth with B2B professional sales and emerging value-based payer channels. Consumer revenue comes from unit device sales online and on Amazon; professional revenue comes from wholesale ordering and free sample programs for optometrists, ophthalmologists, and clinics using the device both in-office (diagnostic drops, dilating drops) and for patient dispensing. In April 2026, the company entered a strategic pharmacy benefit channel via the MediSplit program with MedOne PBM, embedding the device into a value-based benefit structure that has demonstrated 36% prescription cost reduction and 100% adherence among participants. The company has raised approximately $1.9M in disclosed funding (2020 SBIR grant, 2021 seed, 2023 non-dilutive grant), was named a 2025 MN Cup Grand Prize winner, and is transitioning toward the broader Mu Medical platform.

Name

Nanodropper

Legal name

Nanodropper, Inc.

Website

https://nanodropper.com

Company type

Private

Founded year

2017

Operating status

Operating

Headcount range

11–50 employees

Short description

Nanodropper is a US medical device company that sells an FDA-listed microvolume eyedrop bottle adaptor reducing drop size from 30-50 μL to 7-10 μL, sold D2C online, on Amazon, and through 3,000+ partner eye care clinics across all 50 states, serving glaucoma, dry eye, and post-surgical patients.

Ownership category

akta.pro rank

Product category

Ophthalmic Medical Devices

NAICS

Surgical Appliance and Supplies Manufacturing (339113), Ophthalmic Goods Manufacturing (339115)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Ocular Drug Delivery Devices (Eye Droppers/Inserts) (HLAHAIAL)

akta.pro secondary industry

Dropper Systems (Droppers, Pipettes, Teats) (IMALALAG)

Keywords

• Eye drop adapters
• Ophthalmic medical devices
• Precision drug delivery
• Microvolume dosing
• Glaucoma medication savings

Headquarters

HQ city

Seattle

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales

Revenue model

1. Nanodropper Device Sales: One-time sale of the FDA-listed sterile microvolume eyedrop delivery device. The adaptor is designed for single-bottle use and extends the life of medication bottles by up to 3x, creating cost savings for patients. Sold directly via e-commerce, Amazon, and wholesale to eye care professionals.

Pricing tiers

Go-to-market motion3 records

Distribution channels4 records

Marketing channels7 records

Core offering

Nanodropper designs, manufactures, and sells an FDA-listed sterile Class I medical device adaptor that twists onto standard eye drop bottles to deliver microvolume doses (7–10 μL) instead of conventional 30–50 μL drops, extending medication bottle life up to 3x and reducing waste and side effects. The company distributes through a direct-to-consumer e-commerce site, Amazon, professional wholesale, and a partner clinic network, and complements the hardware with the Eye Drop Score self-assessment tool for patients.

Product overview

Nanodropper offers a portfolio of precision eye drop delivery devices centered on its core FDA-listed microvolume adaptor product. The flagship Nanodropper Adaptor (available in Size 15 and Size 14 variants to fit different bottle sizes) is a sterile Class I medical device that twists onto standard eye drop bottles to deliver smaller, more efficient drops, extending medication life by up to 3x. Complementing the hardware product is the Eye Drop Score, a patient-facing self-assessment tool that helps users evaluate their eye drop routine efficiency and share results with healthcare providers. The company has announced plans to expand into a broader precision eyecare platform under the Mu Medical brand, integrating hardware, home monitoring, and clinical intelligence.

Differentiator

Problem solved

Functional benefit

Products and services

• Nanodropper Adaptor FDA-listed sterile Class I medical device adaptor that twists onto standard eye drop bottles and delivers microvolume doses (7–10 μL) instead of conventional 30–50 μL drops. Available in Size 15 (fits the vast majority of standard eye drop bottles) and Size 14 (covers an additional 7% of bottles with 14mm neck measurements). Sold to individual patients and wholesale to eye care professionals; extends medication bottle life up to 3x, reduces waste and side effects, and is FSA/HSA eligible.
• Eye Drop Score A first-of-its-kind self-check quiz that helps patients on glaucoma, chronic dry eye, or post-operative eye drops assess the efficiency of their treatment routine. Generates downloadable personalized results that patients can share with their eye care provider to support conversations about cost, waste, and adherence.

Quantifiable outcome

• Reduces intraocular pressure by 1.6 mm Hg vs 0.13 mm Hg with conventional drops
• +6 more outcomes

Named customers3 records

Segments5 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Three partnerships are on record, tiered core and flagship.

• MedOnecoreStrategic or Co-development Partner · 2 April 2026MedOne and Nanodropper partnership on the MediSplit program, a value-based pharmacy benefit initiative pairing Nanodropper's precision eye drop delivery device with MedOne's PBM network. Early results show 36% reduction in prescription drug costs, 100% of participants never missed doses due to running out or side effects, and up to $160 PMPM savings. Demonstrates integration of medical devices into pharmacy benefit models.
• Bedo SolutionsflagshipStrategic or Co-development Partner · 9 January 2026Bedo Solutions joined Nanodropper's precision eyecare platform under new corporate identity Mu Medical. The consolidation integrates hardware and software assets to create a comprehensive medtech ecosystem covering drug delivery, home monitoring, and AI-driven clinical intelligence across four product verticals. Formal debut during J.P. Morgan Healthcare Conference week January 2026.
• Viseon LabsflagshipStrategic or Co-development Partner · 9 January 2026Viseon Labs joined Nanodropper's precision eyecare platform under new corporate identity Mu Medical. The consolidation integrates hardware and software assets to create a comprehensive medtech ecosystem covering drug delivery, home monitoring, and AI-driven clinical intelligence across four product verticals. Formal debut during J.P. Morgan Healthcare Conference week January 2026.

Scale indicators8 records

Recent moves7 records

Expansion highlights6 records

Others

• Bausch + Lomb: Major ophthalmic pharmaceutical and device company producing prescription and OTC eye drops. Comparable as both a potential channel partner and potential competitive threat if redesigning bottles.
• Allergan/AbbVie Aesthetics: Major ophthalmic pharmaceutical manufacturer producing branded eye drops including Restasis and Lumigan. Comparable as a key upstream supplier whose bottle designs Nanodropper's adaptor is designed to retrofit.

Direct peers

• Owen Mumford: Medical device company specializing in drug delivery aids including eye drop applicators (OptiCare) and ophthalmic accessories. Closely comparable to Nanodropper in offering patient-facing devices that improve eye drop administration and adherence.
• Aero Pump: Manufacturer of precision ophthalmic dropper bottles and dispensing systems producing calibrated micro-doses for pharmaceutical applications. Highly comparable as a competing supplier of microvolume drop delivery technology.

Broad incumbents

• Becton Dickinson (BD): Large medical technology company with a pharmaceutical systems segment producing drug delivery devices, ophthalmic devices, and injection systems. Broadly comparable as an incumbent with adjacent ocular and drug delivery capabilities.
• Aptar Pharma: Global drug delivery device manufacturer producing ophthalmic dropper bottles, pumps, and dispensing systems for pharmaceutical companies. Directly relevant as a supplier of comparable dropper technology to the pharma industry that Nanodropper targets as end users.
• B. Braun: Medical device and pharmaceutical company producing ophthalmic surgical products and drug delivery solutions. Comparable as an established medtech player overlapping with Nanodropper's drug delivery space.
• Gerresheimer: Global manufacturer of pharmaceutical packaging including glass dropper bottles and plastic ophthalmic containers. Comparable as a primary packaging supplier whose bottle designs influence the market Nanodropper addresses.
• Silgan Dispensing: Major dispensing solutions provider offering ophthalmic dropper tips, pumps, and closures for pharmaceutical and personal care markets. Comparable as an incumbent supplier of dropper components Nanodropper's adaptor sits alongside.

Emerging players

• EyeGate Pharmaceuticals: Specialty pharmaceutical and drug delivery company developing ocular drug delivery platforms. Comparable as a smaller player focused specifically on improving ophthalmic drug administration.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/nanodropper
• LinkedInlinkedin.com/company/nanodropper
• Instagraminstagram.com/nanodropper
• Xx.com/nanodropper

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds3 records

Investors5 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Nanodropper